NSECopy of Newspaper Publication3h ago · 31 Oct 2026, 11:52 am
Copy of Newspaper Publication
CORONA Remedies Limited · CORONA
✦ AI SummaryResults
CORONA Remedies Limited has announced the publication of unaudited financial results for the second quarter and half year ended September 30, 2026, with revenue from operations at ₹35,875.05 lakhs and net profit for the period at ₹1,339.37 lakhs.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
CORONA Remedies Limited has informed the Exchange about Copy of Newspaper Publication
Attachments (1)
📄pdf
Download →
CORONAREMEDIES_31102026115204_Newspaper_Publication_regarding_Unaudited_Financial_Results.pdf
View document text
October 31, 2026
To, To,
Listing Operation Department Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla
Dalal Street, Mumbai-400001 Complex, Bandra (East), Mumbai-400051
(Scrip Code: 544644) (SYMBOL: CORONA)
Dear Sir / Madam,
Sub.: Newspaper Publication of Unaudited Financial Results for the second quarter and half year
ended on September 30, 2026
Kindly note that the Board of Directors, at its meeting held on Friday, October 30, 2026 had
considered and approved the Unaudited Financial Results of the Company (Standalone and
Consolidated) for the second quarter and half year ended on September 30, 2026.
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, we are enclosing herewith the newspaper advertisement of the Unaudited Financial Results,
published today in Financial Express (English and Gujarati).
The extract of aforesaid newspaper publication is also being made available on the website of the
Company at www.coronaremedies.com
You are requested to take note of the above.
Thanking you.
Yours faithfully,
For CORONA Remedies Limited
Chetna Dharajiya
Company Secretary and Compliance Officer
Encl.: A/a
INDIGO PAINTS LIMITED
INDIGO
RegisteredOffice:IndigoTower,Street-5,PallodFarm-2,
Besurprised! BanerRoad,Pune,Maharashtra-411045
Corporate Identity Number: L24114PN2000PLC014669
Extract of consolidated and standalone undudited financial results
for the quarter and six months ended September 30, 2026
(All amounts in INR lakhs, unless otherwise stated)
Consolidated
Sr. Quarter ended Six months ended Year ended
Particulars
Sep 30, 2026 Jun 30, 2026 Sep 30, 2025 Sep 30, 2026 Sep 30, 2025 Mar 31, 2026
(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited)
1 Revenue from operations 35,875.05 36,967.08 31,205.91 72,842.13 62,092.30 1,40,501.68
2 Netprofitfortheperiodbeforeexceptionalitems* 1,665.63 5,603.21 3,376.57 7,268.84 6,851.99 20,459.19
3 Netprofitfortheperiodbeforetax* 1,665.63 5,603.21 3,376.57 7,268.84 6,851.99 19,845.88
4 Netprofitfortheperiodaftertax* 1,339.37 4,170.32 2,524.96 5,509.69 5,130.73 14,760.77
5 Totalcomprehensiveincomefortheperiod 1,331.16 4,162.10 2,521.66 5,493.26 5,124.14 14,727.91
6 Equitysharecapital 4,773.27 4,767.57 4,767.57 4,773.27 4,767.57 4,767.57
7 Reservesexcludingrevaluationreservesasat 1,10,629.10
BalanceSheetdate
8 EarningsPerShare (FaceValueofINR10/-each)(not
annualised)
-Basic(FaceValueofINR10/-each) 2.80 8.76 5.27 11.56 10.71 30.44
-Diluted(FaceValueofINR10/-each) 2.80 8.72 5.26 11.52 10.68 30.34
* There are no extraordinary items in any of the period disclosed above.
Note:
1) TheaboveisanextractofthedetailedformatofunauditedfinancialresultsfiledwiththeStockExchangesunderRegulation33oftheSEBI(ListingObligationand
DisclosureRequirements)Regulations,2015.ThefullformatoftheunauditedfinancialresultsisavailableontheStockExchangewebsites(URL:https://www.
nseindia.com,https://www.bseindia.com)andalsoontheCompany’swebsite(URL:https://www.indigopaints.com).Thesamecanbeaccessedbyscanningthe
QR code provided below.
2) KeyfinancialfiguresforIndigoPaintsLimited(standalone)areasfollows:
Quarter ended Six months ended Year ended
No. Particulars Sep 30, 2026 Jun 30, 2026 Sep 30, 2025 Sep 30, 2026 Sep 30, 2025 Mar 31, 2026
(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited)
1 Revenue from operations 34,048.45 35,004.54 29,850.18 69,052.99 59,335.40 1,33,011.82
2 Netprofitfortheperiodbeforeexceptionalitems* 1,723.36 5,692.93 3,413.64 7,416.29 6,931.21 20,112.36
3 Netprofitfortheperiodbeforetax* 1,723.36 5,692.93 3,413.64 7,416.29 6,931.21 19,527.03
4 Netprofitfortheperiodaftertax* 1,380.80 4,236.53 2,553.31 5,617.33 5,189.04 14,538.78
5 Totalcomprehensiveincomefortheperiod 1,370.00 4,225.74 2,547.55 5,595.74 5,177.53 14,495.62
6 Equitysharecapital 4,773.27 4,767.57 4,767.57 4,773.27 4,767.57 4,767.57
7 Reservesexcludingrevaluationreservesasat 1,13,467.22
BalanceSheetdate
8 EarningsPerShare (FaceValueofINR10/-each)(not
annualised)
-Basic(FaceValueofINR10/-each) 2.90 8.89 5.36 11.79 10.89 30.51
-Diluted(FaceValueofINR10/-each) 2.90 8.85 5.35 11.75 10.86 30.41
For Indigo Paints Limited
Sd/-
Hemant Jalan
Chairman & Managing Director
Place : Pune DIN : 00080942
Date : October 30, 2026